You are here

  • Home
  • Archive
  • Volume 14, Issue 9
  • Severe pleural effusion associated with nilotinib for chronic myeloid leukaemia: cross-intolerance with tyrosine kinase inhibitors

Article info

Article menu
Download PDFPDF
Case report
Severe pleural effusion associated with nilotinib for chronic myeloid leukaemia: cross-intolerance with tyrosine kinase inhibitors

Authors

  1. Correspondence to Dr Kasumi Satoh; satohkasumi19900114{at}gmail.com
View Full Text

Citation

Satoh K, Morisawa S, Okuyama M, et al
Severe pleural effusion associated with nilotinib for chronic myeloid leukaemia: cross-intolerance with tyrosine kinase inhibitors
BMJ Case Reports CP 2021;14:e243671.

Publication history

  • Accepted August 24, 2021
  • First published September 3, 2021.
Online issue publication 
January 25, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© BMJ Publishing Group Limited 2021. No commercial re-use. See rights and permissions. Published by BMJ.